On September 25, 2025, Automatic Data Processing Inc. (ADP) announced the nomination of Karen S. Lynch and Robert H. Swan to its Board of Directors. The nominations were made in connection with ADP’s upcoming Annual Meeting of Stockholders on November 12, 2025. Lynch, a veteran of the health‑care industry, served as President and Chief Executive Officer of CVS Health Corporation from 2021 to 2024 and previously led Aetna from 2015 to 2021. Swan, a former CEO and CFO of Intel and an operating partner at Andreessen Horowitz, brings extensive global operational and financial expertise.
The addition of Lynch and Swan expands ADP’s board with leaders who have deep experience in regulated industries, technology operations, and large‑scale corporate governance. Their backgrounds align with ADP’s strategic priorities of enhancing technology capabilities, expanding global reach, and strengthening compliance and risk management. The board’s new composition is expected to support ADP’s continued focus on delivering human‑centric HCM solutions and driving long‑term shareholder value.
Thomas J. Lynch, ADP’s independent non‑executive chair, welcomed the nominations, noting that the nominees’ “wealth of broad‑based experiences” will be invaluable as ADP executes on its three strategic priorities. CEO Maria Black also highlighted the importance of the new board members in advancing ADP’s mission to provide easy‑to‑use, AI‑powered HCM technology. The nominations underscore ADP’s commitment to governance excellence and strategic leadership as it navigates a dynamic market environment.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.